- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03630783
Combined CBM For Social Anxiety in Turkey
Combined Cognitive Bias Modification for Social Anxiety: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A 2 (group: experimental, control) × 3 (time: pretest, posttest, follow-up) experimental design was employed. All participants were presented with informed consent form beforehand, and also verbally informed about the procedure. They were assigned to experimental (E) or attention placebo control (C) groups for 2 sessions per week, 8 sessions in total. Before the first session (pretest) and after the last session (posttest), participants were asked to answer self-report questionnaires, and their attentional and interpretational biases were assessed. And finally, participants were asked only to answer to the same questionnaires for the follow up measurements after two months.
Chi square test and independent t-test for dependent variables were run beforehand to check if participants were equally distributed to Bias Modification group-E and group-C. No statistically significant difference between group-E and group-C was observed with regards to gender distribution, social anxiety, anxiety, depression, dysfunctional thoughts, automatic thoughts, and attentional and interpretational biases.
To see the effect of 8 sessions of manipulation on attentional and interpretational bias (independent variable) created a significant difference between experimental and control groups, 2 (group: experimental [E] and control [C]) × 3 (time: pre [t1] / post [t2] / follow-up [t3]) mixed ANOVA was conducted for each dependent variable in self-report measurements, and 2 (group: experimental [E] and control [C]) × 2 (time: pre [t1] / post [t2]) mixed ANOVA were conducted for attentional and interpretational biases.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
İstanbul
-
Küçükçekmece, İstanbul, Turkey, 34303
- Volkan Koç
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Scoring above 68 on the Liebowitz Social Anxiety Scale
Exclusion Criteria:
- Having any psychiatric disorder
- Receiving a psychiatric/psychological treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Bias Modification (Group-E)
Participants were subjected to Combined Cognitive Bias Modification in each session.
During the attentional bias modification phase, photographs of neutral or threatening (disgusted) faces were used.
In each trial, a pair was shown for 500 ms.
Then, a sign of arrow appeared and participants were asked to indicate the direction of the arrow.
In %80 of the trials, the arrow was in the same area with the neutral photograph.
During the interpretational bias modification phase a threatening or positive word, as the interpretation of a sentence, appeared, then, a relevant sentence with ambiguous meaning appeared, and later, participants were asked to indicate if the word and the sentence were related.
After their response a feedback (right/wrong) was given and the next trial was started.
|
|
|
Placebo Comparator: Placebo Control (Group-C)
Participants in this group were subjected to the same procedure as the experimental group.
However, during the Combined Cognitive Bias Modification process, the sign of arrow appeared at even rates (%50 - %50) after neutral and disgusted facial impressions; and during the interpretational bias modification, sentences and relevant words were superficially related or were not related at all.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social anxiety
Time Frame: Day 0, pre-intervention
|
Social anxiety symptoms were assessed with the Turkish version of the Liebowitz Social Anxiety Scale.
The scale constitutes of 48 items.
The lowest possible score is 48 and highest score is 192.
Higher scores indicate a worse outcome.
|
Day 0, pre-intervention
|
|
Social anxiety
Time Frame: 4 weeks
|
Social anxiety symptoms were assessed with the Turkish version of the Liebowitz Social Anxiety Scale.
The scale constitutes of 48 items.
The lowest possible score is 48 and highest score is 192.
Higher scores indicate a worse outcome.
|
4 weeks
|
|
Social anxiety
Time Frame: 12 weeks
|
Social anxiety symptoms were assessed with the Turkish version of the Liebowitz Social Anxiety Scale.
The scale constitutes of 48 items.
The lowest possible score is 48 and highest score is 192.
Higher scores indicate a worse outcome.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: Day 0, pre-intervention
|
Depression symptoms were assessed with the Turkish version of the Beck Depression Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
Day 0, pre-intervention
|
|
Depression
Time Frame: 4 weeks
|
Depression symptoms were assessed with the Turkish version of the Beck Depression Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
4 weeks
|
|
Depression
Time Frame: 12 weeks
|
Depression symptoms were assessed with the Turkish version of the Beck Depression Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
12 weeks
|
|
Anxiety
Time Frame: Day 0, pre-intervention
|
Anxiety symptoms were assessed with the Turkish version of the Beck Anxiety Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
Day 0, pre-intervention
|
|
Anxiety
Time Frame: 4 weeks
|
Anxiety symptoms were assessed with the Turkish version of the Beck Anxiety Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
4 weeks
|
|
Anxiety
Time Frame: 12 weeks
|
Anxiety symptoms were assessed with the Turkish version of the Beck Anxiety Inventory.
The scale constitutes of 21 items.
The lowest possible score is 0 and highest score is 63.
Higher scores indicate a worse outcome.
|
12 weeks
|
|
Automatic Thoughts Questionnaire
Time Frame: Day 0, pre-intervention
|
Automatic thoughts were assessed with the Turkish version of the Automatic Thoughts Questionnaire.
The scale constitutes of 30 items.
The lowest possible score is 30 and highest score is 150.
Higher scores indicate a worse outcome.
|
Day 0, pre-intervention
|
|
Automatic Thoughts Questionnaire
Time Frame: 4 weeks
|
Automatic thoughts were assessed with the Turkish version of the Automatic Thoughts Questionnaire.
The scale constitutes of 30 items.
The lowest possible score is 30 and highest score is 150.
Higher scores indicate a worse outcome.
|
4 weeks
|
|
Automatic Thoughts Questionnaire
Time Frame: 12 weeks
|
Automatic thoughts were assessed with the Turkish version of the Automatic Thoughts Questionnaire.
The scale constitutes of 30 items.
The lowest possible score is 30 and highest score is 150.
Higher scores indicate a worse outcome.
|
12 weeks
|
|
Dysfunctional Attitudes
Time Frame: Day 0, pre-intervention
|
Dysfunctional beliefs were assessed with the Turkish version of the Dysfunctional Attitude Scale.
The scale constitutes of 40 items.
The lowest possible score is 40 and highest score is 280.
Higher scores indicate a worse outcome.
|
Day 0, pre-intervention
|
|
Dysfunctional Attitudes
Time Frame: 4 weeks
|
Dysfunctional beliefs were assessed with the Turkish version of the Dysfunctional Attitude Scale.
The scale constitutes of 40 items.
The lowest possible score is 40 and highest score is 280.
Higher scores indicate a worse outcome.
|
4 weeks
|
|
Dysfunctional Attitudes
Time Frame: 12 weeks
|
Dysfunctional beliefs were assessed with the Turkish version of the Dysfunctional Attitude Scale.
The scale constitutes of 40 items.
The lowest possible score is 40 and highest score is 280.
Higher scores indicate a worse outcome.
|
12 weeks
|
|
Attentional bias
Time Frame: Day 0, pre-intervention
|
Attentional bias was assessed with the Posner paradigm
|
Day 0, pre-intervention
|
|
Attentional bias
Time Frame: 4 weeks
|
Attentional bias was assessed with the Posner paradigm
|
4 weeks
|
|
Interpretational bias
Time Frame: Day 0, pre-intervention
|
Interpretational bias was assessed with the Word Sentence Association Paradigm
|
Day 0, pre-intervention
|
|
Interpretational bias
Time Frame: 4 weeks
|
Interpretational bias was assessed with the Word Sentence Association Paradigm
|
4 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Volkan Koç, PhD, Istanbul Sabahattin Zaim University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IstanbulSZU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phobia, Social
-
San Diego State UniversityNational Institute of Mental Health (NIMH)CompletedSocial Anxiety Disorder | Social PhobiaUnited States
-
Umeå UniversityUppsala UniversityCompleted
-
Umeå UniversityCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedSocial PhobiaUnited States
-
University of MinnesotaAstraZenecaCompletedSocial PhobiaUnited States
-
Modum BadCompleted
-
VU University of AmsterdamCompletedSocial Anxiety Disorder | Social PhobiaNetherlands
-
McMaster UniversityHamilton Health Sciences Corporation; Janssen-Ortho Inc., CanadaTerminated
-
Pherin Pharmaceuticals, Inc.CompletedSocial Anxiety Disorder | Social PhobiaUnited States
Clinical Trials on Combined Cognitive Bias Modification
-
Dokuz Eylul UniversityThe Scientific and Technological Research Council of TurkeyRecruitingObsessive Compulsive Disorder (OCD)Turkey
-
Dokuz Eylul UniversityThe Scientific and Technological Research Council of TurkeyCompletedObsessive-compulsive Disorders and Symptoms | Obsessive Thoughts | Obsessive Compulsive BehaviorTurkey
-
Temple UniversityNot yet recruiting
-
Istanbul Sabahattin Zaim UniversityCompletedPerfectionism | Intolerance to UncertaintyUnited States
-
Universidad Complutense de MadridCompletedDepression | Cognitive ChangeSpain
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioSuspended
-
King's College LondonSouth London and Maudsley NHS Foundation Trust; South West London and St George... and other collaboratorsUnknownEating Disorders in AdolescenceUnited Kingdom
-
Centre for Addiction and Mental HealthAmerican Foundation for Suicide PreventionCompletedSubstance DependenceCanada
-
Ruhr University of BochumUniversity Hospital, EssenCompleted
-
University of SouthamptonEconomic and Social Research Council, United KingdomCompletedChronic Pain | Musculoskeletal Pain DisorderUnited Kingdom